5 completed, 1 enrolling by invitation. 2 Phase 1, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 2 | 1 | Completed 1 |
Follow moexipril: new trials by email Literature Review of moexipril trials Research Report on moexipril
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes | Phase 4 | Enrolling by invitation | Baylor Research Institute | 64 | 2026-04-08 | 2026-10-13 |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery ACEI continuation, ACEI omission - Hypotension on Induction | Phase 4 | Completed | University of Nebraska | 291 | 2015-06-01 | 2023-09-25 |
| Moexipril for Primary Biliary Cirrhosis Moexipril - Primary Biliary Cirrhosis | Phase 2 | Completed | Mayo Clinic | 20 | 2003-06-01 | 2011-05-23 |
| A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions Moexipril HCl 15mg Tablets, Paddock Laboratories, Inc., Univasc® 15mg Tablets - Healthy | Phase 1 | Completed | Paddock Laboratories, Inc. | 60 | 2013-09-26 | |
| A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions Moexipril HCl/ Hydrochlorothiazide 15mg/ 25mg Tablet, Paddock Laboratories, Inc., Uniretic® 15mg/25mg Tablets - Healthy | Phase 1 | Completed | Paddock Laboratories, Inc. | 48 | 2013-11-25 |
Albuminuria (1) · Diabetes Mellitus, Type 2 (1) · Hyperkalemia (1) · Hypertension (1) · Liver Cirrhosis, Biliary (1) · Renal Insufficiency, Chronic (1)
Paddock Laboratories, Inc. (2) · Baylor Research Institute (1) · Mayo Clinic (1) · University of Nebraska (1) · University of Utah (1)
United States (6)
Adam P Bress, PharmD, MS (1) · Jason F Shiffermiller, MD, MPH (1) · Keith D Lindor, MD (1)